Microencapsulation of water-soluble macromolecules with acrylic terpolymers by the Wurster coating process for colon-specific drug delivery

被引:26
作者
Arimoto, M
Ichikawa, H
Fukumori, Y
机构
[1] Kobe Gakuin Univ, Fac Pharmaceut Sci, Nishi Ku, Kobe, Hyogo 6512180, Japan
[2] Kobe Gakuin Univ, High Technol Res Ctr, Nishi Ku, Kobe, Hyogo 6512180, Japan
[3] AZWELL Inc, R&D Div, Dept Pharmaceut Res, Ibaraki, Osaka 6570806, Japan
基金
日本学术振兴会;
关键词
delayed release; coating; Wurster process; acrylic polymer; polyvinylpyrrolidone; microcapsule; colon-specific drug delivery;
D O I
10.1016/j.powtec.2003.10.018
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
The aim of this work is to explore a microcapsule formulation applicable for a peroral colon-specific delivery of water-soluble macromolecules such as peptide drugs, based on our previous delayed-release formulations using self-made colloidal terpolymers of ethyl acrylate, methyl methacrylate and 2-hydroxyethyl methacrylate (poly(EA/MMA/HEMA)). Peptides are thermally unstable and less permeable through a polymeric membrane in general. Thus, the present work was intended to establish the acrylic terpolymers having the following characteristics: an excellent film-formability even at a low process-temperature of 40 degreesC to preserve the stability of heat-sensitive drugs and a desired permeability allowing a delayed-release profile of macromolecular drugs. Using various types of poly(EA/MMA/HEMA) synthesized with different monomer molar ratios, microencapsulation of the particles consisting of a lactose core and a surface-layer of water-soluble fluorescence-labeled dextran (FITC-Dex, Mw 9500), a model of macromolecular solute, was carried out by the Wurster process. The release profiles of FITC-Dex were highly dependent on the terpolymer compositions. The increased EA content made the poly(EA/MMA/HEMA) films flexible and less permeable, leading to significant decrease in release rate of FITC-Dex. Contrary, it was found that the increase in HEMA content enhanced the FITC-Dex release due to the enhanced hydration of the films, as expected from its higher hydrophilicity than the other monomers. Among a series of poly(EA/MMA/HEMA) prepared here, the poly(EA/MMA/HEMA) with the molar ratio of 95:85:40 exhibited a good film-formability in the post-thermal curing process at 40 degreesC. The established coating films allowed delayed-release of the microencapsulated FITC-Dex; the profile was characterized by a lag time and subsequent rapid release. This delayed-release was probably due to time-dependent change of the semi-permeable nature of the hydrated coating films as a consequence of anomalous film-deformation arising from the osmotic pressure inside the microcapsules. Moreover, the release profiles of FITC-Dex were found to be pH-independent. Based on our findings, the use of poly(EA/MMA/HEMA) with molar ratio of 95:85:40 could be proposed as a feasible way to prepare a delayed-release microcapsule containing water-soluble macromolecules by the Wurster coating process, toward the future application to colon-specific delivery of peptide drugs. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:177 / 186
页数:10
相关论文
共 32 条
[1]   AN INVITRO INVESTIGATION INTO THE SUITABILITY OF PH-DEPENDENT POLYMERS FOR COLONIC TARGETING [J].
ASHFORD, M ;
FELL, JT ;
ATTWOOD, D ;
WOODHEAD, PJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 91 (2-3) :241-245
[2]   POLYMER NSR SPECTROSCOPY .2. THE HIGH RESOLUTION SPECTRA OF METHYL METHACRYLATE POLYMERS PREPARED WITH FREE RADICAL AND ANIONIC INITIATORS [J].
BOVEY, FA ;
TIERS, GVD .
JOURNAL OF POLYMER SCIENCE, 1960, 44 (143) :173-182
[3]   A COMPARATIVE-STUDY OF THE GASTROINTESTINAL TRANSIT OF A PELLET AND TABLET FORMULATION [J].
DAVIS, SS ;
HARDY, JG ;
TAYLOR, MJ ;
WHALLEY, DR ;
WILSON, CG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1984, 21 (02) :167-177
[4]  
FOLLONIER N, 1992, STP PHARMA SCI, V2, P141
[5]  
FUKUMORI Y, 1987, CHEM PHARM BULL, V35, P2949
[6]  
FUKUMORI Y, 1988, CHEM PHARM BULL, V36, P3070
[7]  
GAZZANIGA A, 1995, STP PHARMA SCI, V5, P83
[8]   Phosphated crosslinked guar for colon-specific drug delivery II. In vitro and in vivo evaluation in the rat [J].
Gliko-Kabir, I ;
Yagen, B ;
Baluom, M ;
Rubinstein, A .
JOURNAL OF CONTROLLED RELEASE, 2000, 63 (1-2) :129-134
[9]  
Ichikawa H, 1996, CHEM PHARM BULL, V44, P383
[10]  
ICHIKAWA H, 1993, CHEM PHARM BULL, V41, P1132